MegaPro Biomedical
Manufacturing · Taiwan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
no.195 Sec.4 Chung Hsing Rd Chutung, Hsi...Phone Number
+886 35910441Website
www.megaprobio.comRevenue
<$5 MillionIndustry
About MegaPro Biomedical
MegaPro Biomedical Org Chart
Is MegaPro Biomedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when MegaPro Biomedical launches new products
MegaPro Biomedical, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on MegaPro Biomedical recently announced quarterly report
Check out if MegaPro Biomedical is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once MegaPro Biomedical has new funding data
Congratulate Masked Content for being promoted to Masked Content at MegaPro Biomedical
Website visits: Recent activity has been detected on your website
Check if MegaPro Biomedical has recently received funding, and reach out quickly before it becomes old news!
Click to see if MegaPro Biomedical had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined MegaPro Biomedical as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
MegaPro Biomedical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
MegaPro Biomedical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about MegaPro Biomedical.
MegaPro Biomedical Tech Stack
A closer look at the technologies used by MegaPro Biomedical
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MegaPro Biomedical
MegaPro Biomedical is a nanomedicine development company that spin-off from ITRI and has nanoparticle and nano-micelle as the core technology. Currently, the nanoparticle product has two indications namely MPB-1514 iron supplement for iron deficiency anemia and MPB-1523 contrast agent for hepatocellular carcinoma that have been approved by the US F... Read More